Skip to main content
High RiskFDAfda-H-0319-2025UNDECLARED ALLERGEN

Artisan Style 1/2 Loaf, Net wt. 12 oz (340g) 024126018152 1/2 Loaf of white bread with white flour topping and two splits on top 7/13/202...

Units Affected
883
Recall Date
July 2, 2025
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0319-2025.

Undeclared allergen: Hazelnut due to mispackaging. Product with hazelnuts was put in the Artisan Style 1/2 loaf bags. Bags do not have allergen statement that includes hazelnuts.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0319-2025.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Lewis Bakeries or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0319-2025.

LEWIS BAKERIES

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Lewis Bakeries Recall FAQ

Lewis Bakeries is the subject of a bakery & grains safety report: Artisan Style 1/2 Loaf, Net wt. 12 oz (340g) 024126018152 1/2 Loaf of white bread with white flour topping and two splits on top 7/13/202.... The notice was published on July 2, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 883 units are potentially affected.